BJGP Study Highlights Eight Early Symptoms Of Cancer
Eight clinical features that predict cancer at a high probability rate which could improve early diagnosis have been identified by researchers writing in this month's British Journal of General Practice (BJGP)...
GWCI Receives $2.4 Million Grant To Establish D.C. City-Wide Patient Navigation Network (CPNN)
The GW Cancer Institute (GWCI) was recently awarded a $2.4 million grant from the D.C. Cancer Consortium to establish and coordinate a City-wide Patient Navigation Network (CPNN) in Washington, D.C. The CPNN will create a seamless cohesive framework for cancer care coordination across the entire city. The CPNN will ensure that all D.C...
New Research Confirms Skin Cancer Prevention One Of The Nation's Best Health Investments
The Australian Government should act on comprehensive new research and run an intensive SunSmart campaign to reduce Australia's unacceptable skin cancer burden, Cancer Council Australia said today...
The Risk Of Childhood Cancer Following Fetal Exposure To Radiation
Fetal exposure to radiation and the risk of childhood cancer: what is the likelihood of a risk? A new study published in this week's PLoS Medicine aims to evaluate the possibility that exposure of a fetus to computed tomography or radionuclide imaging performed during pregnancy might increase subsequent risk of childhood cancer...
2nd Annual Cancer Targets And Therapeutics Conference, Oct 20-22, San Francisco, CA
Dr. Patrick Baeuerle, Vice President of Micromet, to present as a featured speaker at GTCbio's 2nd Annual Cancer Targets and Therapeutics Conference, part of the 6th Modern Drug Discovery and Development Summit on Oct. 20-22, 2010 in San Francisco, CA. Dr. Baeuerle will give a presentation on "BiTE Antibody-Engaged T-Cells for Cancer Therapy...
Non-Hormone Treatments Can Relieve Hot Flashes In Women With Breast Cancer
Many women enduring hot flashes experience the heat, sweat and reddened upper body as an uncomfortable inconvenience. However, hot flashes can greatly diminish a woman's quality of life, disrupting sleep at night or causing embarrassment as she goes about her daily business. Hot flashes, called flushes in medical circles, occur commonly in women with a history of breast cancer...
Review: Helping Kids Cope With Chemo
Although nausea and vomiting are common in children undergoing chemotherapy, few quality studies identify absolutely the best way to prevent and treat this problem in kids, said Robert Phillips, M.D., lead author of a new Cochrane review. Phillips, a pediatric oncologist at St. James's Hospital in Leeds, England, said the main finding is the paucity of data that he and his colleagues uncovered...
Chemotherapy Drug Does Not Improve Overall Survival After Resection Of Pancreatic Cancer Compared To More Common Treatment
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA...
Prophylactic Surgeries Associated With Lower Risk Of Cancer For Women With BRCA1/2 Gene Mutations
Women at increased risk of breast and ovarian cancer because of inherited mutations of the BRCA1 or BRCA2 genes who had prophylactic mastectomy or salpingo-oophorectomy (removal of the fallopian tubes and ovaries) had an associated decreased risk of breast cancer and ovarian cancer, according to a study in the September 1 issue of JAMA...
St. Jude Researcher Receives Grant To Focus On Cancer Pharmacogenomics In Children
With its new expansion of the Pharmacogenomics Research Network (PGRN), the National Institutes of Health (NIH) awarded St. Jude Children's Research Hospital a prestigious grant to focus on anticancer agent research in children. The five-year, $8.6 million grant is titled "PAAR4Kids Pharmacogenomics of Anticancer Agents Research in Children." "We've been part of the PGRN for 10 years...
Researchers Uncover Activation Signal For Aurora-A Oncogene
Aurora-A kinase (AurA) is an enzyme that is hyperactive in many cancers and drives tumor cell proliferation. Several AurA inhibitors are currently being tested in clinical trials to see if they slow tumor growth. Now, researchers in the Developmental Therapeutics Program at Fox Chase Cancer Center have identified an activation signal for AurA...
The Capacity Of 4-HPR To Induce Death Of Tumour Cells, Applying It To Acute Lymphoblastic Leukaemia
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25% of cases and which can lead to death...
Scientists Create New Process To 'Program' Cancer Cell Death
Researchers at the California Institute of Technology (Caltech) have engineered a fundamentally new approach to killing cancer cells...
Low Carb Plant Sourced Diet Better Than Animal Sourced One
If you want to live longer, you are better off on a low carb diet which is vegetable based, rather than one whose proteins are sourced from animals, according to a study involving 129,716 men and women published this week in the medical journal Annals of Internal Medicine...
NHS Choices: Six Warning Signs Of Cancer
More than 1/3 people in the UK will develop some form of cancer during their lifetime. The good news is that some cancers can be cured if detected early enough. The key is to be aware of unexplained changes to your body, and to know the common signs and symptoms of cancer...
Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Metastatic Breast Cancer
Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90 per cent of metastatic breast carcinoma (MBC) patients. Correlations were observed with both the patients' monocyte (i.e...
Hallucinogen Found To Safely Ease Anxiety In Advanced-Stage Cancer Patients
In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online in the Archives of General Psychiatry...
Poor Public Awareness Highlights Radiotherapy's 'Cinderella' Status
Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures* published by Cancer Research UK today (Tuesday). The survey of more than 2,000 people from across the UK also reveals just 14 per cent are aware that half of all cancer patients could benefit from radiotherapy as part of their treatment...
New Treatment Activates Death Program In Cancer Cells
Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells...
Blocking HMGB1 May Benefit Cancer Patients
Like some people, cells eat when they are under pressure - but they consume parts of themselves. A multi-function protein helps control this form of cannibalism, according to a study in the September 6 issue of the Journal of Cell Biology. Cells often respond to hunger or stress by digesting some of their contents...
Magic Mushroom Ingredient Psilocybin Improves Late Stage Cancer Anxiety
The hallucinogen psilocybin appears to be safe and feasible to give to patients with advanced-stage cancer and anxiety - a study published in Archives of General Psychiatry reports it had a promising effect on mood. Psilocybin is the active ingredient in an illegal Class A drug in the UK called magic mushroom...
First Radiation Oncologist Hired For BC Cancer Agency Centre For The North And Appointed To The Northern Medical Program
Dr. Robert Olson, a radiation oncologist, is the first physician to be hired for the BC Cancer Agency Centre for the North. He will be part of the provincial Radiation Therapy Program which will bring service to the North for the first time when the new centre is opened. The centre, now under construction, is expected to start treating patients by the end of 2012. Dr...
CSI Laboratories To Build New Cancer Diagnostics Laboratory In Atlanta, GA
CSI Laboratories®, a private national cancer diagnostic laboratory, announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta. CSI Laboratories is committing $15 million to its strategic expansion project, and this newly leased space will house its next generation laboratory, with clinical operations beginning in mid-2011...
Celgene Officially Notified Of ANDA Filing For REVLIMID(R)
Celgene Corporation (NASDAQ: CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA)...
Increased Risk Of Second Cancers And Earlier Death For Childhood Cancer Survivors, Australia
Progress in childhood cancer is a good news story. Children treated for cancer have an overall 70-80 per cent cure rate. As the numbers of survivors of childhood cancer increases, studies of the long-term survivors allow research that can guide newer treatment protocols and further improve the outlook for newly diagnosed patients...
